Neuromuscular blockers, nondepolarizing

Results 31 to 40 of about 464 (112)

Peripheral nervous system and neuromuscular disorders in the emergency department: A review

Academic Emergency Medicine, Volume 31, Issue 4, Page 386-397, April 2024.
Abstract Introduction Acute presentations and emergencies in neuromuscular disorders (NMDs) often challenge clinical acumen. The objective of this review is to refine the reader's approach to history taking, clinical localization and early diagnosis, as well as emergency management of neuromuscular emergencies.
Ajith Sivadasan +3 more
wiley +1 more source

Efficacy and safety of adamgammadex for reversing rocuronium‐induced deep neuromuscular blockade: A multicenter, randomized, phase IIb study

Clinical and Translational Science, Volume 17, Issue 1, January 2024.
Abstract The rapid reversal of deep neuromuscular blockade (NMB) is important but remains challenging. This study aimed to evaluate the efficacy and safety of adamgammadex versus sugammadex in reversing deep rocuronium‐induced NMB. This multicenter, randomized, phase IIb study included 80 patients aged 18–64 years, American Society of Anesthesiologists
Yanhua Zhao +10 more
wiley +1 more source

Anesthetic Management and Neuromonitoring in a Patient with Very Long‐Chain Acyl‐Coenzyme A Dehydrogenase Deficiency Undergoing Scoliosis Surgery: A Case Report and Review of Literature

Case Reports in Anesthesiology, Volume 2024, Issue 1, 2024.
Patients with very long‐chain acyl‐CoA dehydrogenase deficiency (VLCADD) are prone to hypoglycemia and clinical decompensation when metabolic demands of the body are not met. We present a pediatric patient with VLCADD who underwent a posterior spinal fusion for scoliosis requiring intraoperative neurophysiology monitoring.
Anna Tanaka +5 more
wiley +1 more source

A Normal Distribution Model for the Pharmacodynamics of Nondepolarizing Neuromuscular Blockers [PDF]